Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.

Kovarik JJ, Kaltenecker CC, Kopecky C, Domenig O, Antlanger M, Werzowa J, Eskandary F, Kain R, Poglitsch M, Schmaldienst S, Böhmig GA, Säemann MD.

Sci Rep. 2019 Jul 5;9(1):9762. doi: 10.1038/s41598-019-46114-x.

2.

Prospective multicenter randomized patient recruitment and sample collection to enable future measurements of sputum biomarkers of inflammation in an observational study of cystic fibrosis.

Liou TG, Adler FR, Argel N, Asfour F, Brown PS, Chatfield BA, Daines CL, Durham D, Francis JA, Glover B, Heynekamp T, Hoidal JR, Jensen JL, Keogh R, Kopecky CM, Lechtzin N, Li Y, Lysinger J, Molina O, Nakamura C, Packer KA, Poch KR, Quittner AL, Radford P, Redway AJ, Sagel SD, Sprandel S, Taylor-Cousar JL, Vroom JB, Yoshikawa R, Clancy JP, Elborn JS, Olivier KN, Cox DR.

BMC Med Res Methodol. 2019 Apr 26;19(1):88. doi: 10.1186/s12874-019-0705-0.

3.

Molecular regulation of the renin-angiotensin system by sodium-glucose cotransporter 2 inhibition in type 1 diabetes mellitus.

Kopecky C, Lytvyn Y, Domenig O, Antlanger M, Kovarik JJ, Kaltenecker CC, Poglitsch M, Perkins BA, Rye KA, Cherney DZI, Säemann MD.

Diabetologia. 2019 Jun;62(6):1090-1093. doi: 10.1007/s00125-019-4871-8. Epub 2019 Apr 11. No abstract available.

PMID:
30976852
4.

Translocator protein localises to CD11b+ macrophages in atherosclerosis.

Kopecky C, Pandzic E, Parmar A, Szajer J, Lee V, Dupuy A, Arthur A, Fok S, Whan R, Ryder WJ, Rye KA, Cochran BJ.

Atherosclerosis. 2019 May;284:153-159. doi: 10.1016/j.atherosclerosis.2019.03.011. Epub 2019 Mar 18.

PMID:
30913515
5.

High-Density Lipoprotein from Chronic Kidney Disease Patients Modulates Polymorphonuclear Leukocytes.

Raupachova J, Kopecky C, Cohen G.

Toxins (Basel). 2019 Feb 1;11(2). pii: E73. doi: 10.3390/toxins11020073.

6.

Empagliflozin in posttransplantation diabetes mellitus: A prospective, interventional pilot study on glucose metabolism, fluid volume, and patient safety.

Schwaiger E, Burghart L, Signorini L, Ristl R, Kopecky C, Tura A, Pacini G, Wrba T, Antlanger M, Schmaldienst S, Werzowa J, Säemann MD, Hecking M.

Am J Transplant. 2019 Mar;19(3):907-919. doi: 10.1111/ajt.15223. Epub 2019 Jan 25.

7.

TPP2 mutation associated with sterile brain inflammation mimicking MS.

Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschländer A, Meuth SG, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick AD, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A.

Neurol Genet. 2018 Nov 13;4(6):e285. doi: 10.1212/NXG.0000000000000285. eCollection 2018 Dec.

8.

A randomized controlled trial-based algorithm for insulin-pump therapy in hyperglycemic patients early after kidney transplantation.

Werzowa JM, Säemann MD, Mohl A, Bergmann M, Kaltenecker CC, Brozek W, Thomas A, Haidinger M, Antlanger M, Kovarik JJ, Kopecky C, Song PXK, Budde K, Pascual J, Hecking M.

PLoS One. 2018 Mar 8;13(3):e0193569. doi: 10.1371/journal.pone.0193569. eCollection 2018.

9.

Sports and HDL-Quality Reflected By Serum Amyloid A and Surfactant Protein B.

Sponder M, Kopecky C, Campean IA, Emich M, Fritzer-Szekeres M, Litschauer B, Graf S, Säemann MD, Strametz-Juranek J.

Int J Med Sci. 2017 Sep 3;14(11):1040-1048. doi: 10.7150/ijms.20388. eCollection 2017.

10.

Pro- versus Anti-inflammatory Actions of HDLs in Innate Immunity.

Kopecky C, Michlits G, Säemann MD, Weichhart T.

Cell Metab. 2017 Jul 5;26(1):2-3. doi: 10.1016/j.cmet.2017.04.007. Epub 2017 Jun 22.

11.

Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Antlanger M, Domenig O, Kovarik JJ, Kaltenecker CC, Kopecky C, Poglitsch M, Säemann MD.

J Renin Angiotensin Aldosterone Syst. 2017 Apr-Jun;18(2):1470320317705232. doi: 10.1177/1470320317705232.

12.

Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis.

Antlanger M, Aschauer S, Kopecky C, Hecking M, Kovarik JJ, Werzowa J, Mascherbauer J, Genser B, Säemann MD, Bonderman D.

Kidney Blood Press Res. 2017;42(1):165-176. doi: 10.1159/000473868. Epub 2017 Apr 11.

13.

Effects of direct renin inhibition versus angiotensin II receptor blockade on angiotensin profiles in non-diabetic chronic kidney disease.

Antlanger M, Bernhofer S, Kovarik JJ, Kopecky C, Kaltenecker CC, Domenig O, Poglitsch M, Säemann MD.

Ann Med. 2017 Sep;49(6):525-533. doi: 10.1080/07853890.2017.1313447. Epub 2017 Apr 17.

PMID:
28358246
14.

Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.

Kovarik JJ, Kopecky C, Antlanger M, Domenig O, Kaltenecker CC, Werzowa J, Hecking M, Mahr S, Grömmer M, Wallner C, Aumayr K, Kain R, Zuckermann A, Poglitsch M, Säemann MD.

J Heart Lung Transplant. 2017 Mar;36(3):355-365. doi: 10.1016/j.healun.2016.08.022. Epub 2016 Sep 13.

PMID:
27773450
15.

HDL Cholesterol Efflux Does Not Predict Cardiovascular Risk in Hemodialysis Patients.

Kopecky C, Ebtehaj S, Genser B, Drechsler C, Krane V, Antlanger M, Kovarik JJ, Kaltenecker CC, Parvizi M, Wanner C, Weichhart T, Säemann MD, Tietge UJ.

J Am Soc Nephrol. 2017 Mar;28(3):769-775. doi: 10.1681/ASN.2016030262. Epub 2016 Sep 9.

16.

Molecular regulation of the renin-angiotensin system in haemodialysis patients.

Kovarik JJ, Antlanger M, Domenig O, Kaltenecker CC, Hecking M, Haidinger M, Werzowa J, Kopecky C, Säemann MD.

Nephrol Dial Transplant. 2016 May;31(5):851. doi: 10.1093/ndt/gfw071. Epub 2016 Mar 23. No abstract available.

PMID:
27190396
17.

Improve huddles with whiteboards.

Pruett D, Kopecky C.

Fam Pract Manag. 2016 Mar-Apr;23(2):34. No abstract available.

18.

Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.

Zewinger S, Drechsler C, Kleber ME, Dressel A, Riffel J, Triem S, Lehmann M, Kopecky C, Säemann MD, Lepper PM, Silbernagel G, Scharnagl H, Ritsch A, Thorand B, de las Heras Gala T, Wagenpfeil S, Koenig W, Peters A, Laufs U, Wanner C, Fliser D, Speer T, März W.

Eur Heart J. 2015 Nov 14;36(43):3007-16. doi: 10.1093/eurheartj/ehv352. Epub 2015 Aug 6.

PMID:
26248570
19.

HDL cholesterol efflux capacity and cardiovascular events.

Kopecky C, Weichhart T, Säemann MD.

N Engl J Med. 2015 May 7;372(19):1869. doi: 10.1056/NEJMc1503139. No abstract available.

PMID:
25946299
20.

Post-transplantation diabetes mellitus: evaluation of treatment strategies.

Haidinger M, Antlanger M, Kopecky C, Kovarik JJ, Säemann MD, Werzowa J.

Clin Transplant. 2015 May;29(5):415-24. doi: 10.1111/ctr.12541.

PMID:
25777150
21.

Dialysis Modalities and HDL Composition and Function.

Holzer M, Schilcher G, Curcic S, Trieb M, Ljubojevic S, Stojakovic T, Scharnagl H, Kopecky CM, Rosenkranz AR, Heinemann A, Marsche G.

J Am Soc Nephrol. 2015 Sep;26(9):2267-76. doi: 10.1681/ASN.2014030309. Epub 2015 Mar 5.

22.

Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.

Kopecky C, Genser B, Drechsler C, Krane V, Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD, Weichhart T.

Clin J Am Soc Nephrol. 2015 Feb 6;10(2):224-31. doi: 10.2215/CJN.06560714. Epub 2014 Nov 25.

23.

Molecular regulation of the renin-angiotensin system in haemodialysis patients.

Kovarik JJ, Antlanger M, Domenig O, Kaltenecker CC, Hecking M, Haidinger M, Werzowa J, Kopecky C, Säemann MD.

Nephrol Dial Transplant. 2015 Jan;30(1):115-23. doi: 10.1093/ndt/gfu265. Epub 2014 Aug 8. Erratum in: Nephrol Dial Transplant. 2016 May;31(5):851.

PMID:
25107336
24.

Restoration of renal function does not correct impairment of uremic HDL properties.

Kopecky C, Haidinger M, Birner-Grünberger R, Darnhofer B, Kaltenecker CC, Marsche G, Holzer M, Weichhart T, Antlanger M, Kovarik JJ, Werzowa J, Hecking M, Säemann MD.

J Am Soc Nephrol. 2015 Mar;26(3):565-75. doi: 10.1681/ASN.2013111219. Epub 2014 Jul 28.

25.

Known players, new interplay in atherogenesis: Chronic shear stress and carbamylated-LDL induce and modulate expression of atherogenic LR11 in human coronary artery endothelium.

Bajari TM, Winnicki W, Gensberger ET, Scharrer SI, Regele H, Aumayr K, Kopecky C, Gmeiner BM, Hermann M, Zeillinger R, Sengölge G.

Thromb Haemost. 2014 Feb;111(2):323-32. doi: 10.1160/TH12-12-0924. Epub 2013 Nov 28.

PMID:
24284991
26.

Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.

Haidinger M, Werzowa J, Hecking M, Antlanger M, Stemer G, Pleiner J, Kopecky C, Kovarik JJ, Döller D, Pacini G, Säemann MD.

Am J Transplant. 2014 Jan;14(1):115-23. doi: 10.1111/ajt.12518. Epub 2013 Nov 26.

27.

Hereditary amyloidosis caused by R554L fibrinogen Aα-chain mutation in a Spanish family and review of the literature.

Haidinger M, Werzowa J, Kain R, Antlanger M, Hecking M, Pfaffenberger S, Mascherbauer J, Gremmel T, Gilbertson JA, Rowczenio D, Weichhart T, Kopecky C, Hörl WH, Hawkins PN, Säemann MD.

Amyloid. 2013 Jun;20(2):72-9. doi: 10.3109/13506129.2013.781998. Epub 2013 Apr 3.

PMID:
23551149
28.

Use of noninsulin antidiabetic medications in hospitalized patients.

Kopecky C.

Crit Care Nurs Clin North Am. 2013 Mar;25(1):39-53. doi: 10.1016/j.ccell.2012.11.012. Epub 2012 Dec 12. Review.

PMID:
23410645
29.

Abnormal infant pulmonary function in young children with neuroendocrine cell hyperplasia of infancy.

Kerby GS, Wagner BD, Popler J, Hay TC, Kopecky C, Wilcox SL, Quinones RR, Giller RH, Accurso FJ, Deterding RR.

Pediatr Pulmonol. 2013 Oct;48(10):1008-15. doi: 10.1002/ppul.22718. Epub 2012 Nov 20.

PMID:
23169677
30.

Serum amyloid A in uremic HDL promotes inflammation.

Weichhart T, Kopecky C, Kubicek M, Haidinger M, Döller D, Katholnig K, Suarna C, Eller P, Tölle M, Gerner C, Zlabinger GJ, van der Giet M, Hörl WH, Stocker R, Säemann MD.

J Am Soc Nephrol. 2012 May;23(5):934-47. doi: 10.1681/ASN.2011070668. Epub 2012 Jan 26.

31.

Apoptotic cell-free DNA promotes inflammation in haemodialysis patients.

Atamaniuk J, Kopecky C, Skoupy S, Säemann MD, Weichhart T.

Nephrol Dial Transplant. 2012 Mar;27(3):902-5. doi: 10.1093/ndt/gfr695. Epub 2011 Dec 13.

PMID:
22167588
32.

IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression.

Chmielewski M, Kopecky C, Hombach AA, Abken H.

Cancer Res. 2011 Sep 1;71(17):5697-706. doi: 10.1158/0008-5472.CAN-11-0103. Epub 2011 Jul 8.

33.

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cells.

Weichhart T, Haidinger M, Katholnig K, Kopecky C, Poglitsch M, Lassnig C, Rosner M, Zlabinger GJ, Hengstschläger M, Müller M, Hörl WH, Säemann MD.

Blood. 2011 Apr 21;117(16):4273-83. doi: 10.1182/blood-2010-09-310888. Epub 2011 Mar 2.

34.

Eradication of melanomas by targeted elimination of a minor subset of tumor cells.

Schmidt P, Kopecky C, Hombach A, Zigrino P, Mauch C, Abken H.

Proc Natl Acad Sci U S A. 2011 Feb 8;108(6):2474-9. doi: 10.1073/pnas.1009069108. Epub 2011 Jan 31.

35.

The versatility of HDL: a crucial anti-inflammatory regulator.

Säemann MD, Poglitsch M, Kopecky C, Haidinger M, Hörl WH, Weichhart T.

Eur J Clin Invest. 2010 Dec;40(12):1131-43. doi: 10.1111/j.1365-2362.2010.02361.x. Review.

PMID:
20695882
36.

Prior history of physical and sexual abuse among the psychiatric inpatient population: a comparison of males and females.

Shack AV, Averill PM, Kopecky C, Krajewski K, Gummattira P.

Psychiatr Q. 2004 Winter;75(4):343-59.

PMID:
15563052
37.

Is schizoaffective disorder a stable diagnostic category: a retrospective examination.

Averill PM, Reas DL, Shack A, Shah NN, Cowan K, Krajewski K, Kopecky C, Guynn RW.

Psychiatr Q. 2004 Fall;75(3):215-27.

PMID:
15335225
38.

Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.

Grabowski J, Rhoades H, Stotts A, Cowan K, Kopecky C, Dougherty A, Moeller FG, Hassan S, Schmitz J.

Neuropsychopharmacology. 2004 May;29(5):969-81.

39.

New subscales for an anchored version of the Brief Psychiatric Rating Scale: construction, reliability, and validity in acute psychiatric admissions.

Lachar D, Bailley SE, Rhoades HM, Espadas A, Aponte M, Cowan KA, Gummattira P, Kopecky CR, Wassef A.

Psychol Assess. 2001 Sep;13(3):384-95.

PMID:
11556275
40.

Group F streptococcal bacteremia complicating a Bartholin's abscess.

DeAngelo AJ, Dooley DP, Skidmore PJ, Kopecky CT.

Infect Dis Obstet Gynecol. 2001;9(1):55-7.

41.

The prevalence of celiac disease autoantibodies in patients with systemic lupus erythematosus.

Rensch MJ, Szyjkowski R, Shaffer RT, Fink S, Kopecky C, Grissmer L, Enzenhauer R, Kadakia S.

Am J Gastroenterol. 2001 Apr;96(4):1113-5.

PMID:
11316156
42.

Reliability and validity of the Overt Agitation Severity Scale in adult psychiatric inpatients.

Kopecky HJ, Kopecky CR, Yudofsky SC.

Psychiatr Q. 1998 Winter;69(4):301-23.

PMID:
9793109

Supplemental Content

Loading ...
Support Center